本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tyra Biosciences, Inc.

25.31
-0.1200-0.47%
成交量:47.38萬
成交額:1,206.87萬
市值:15.06億
市盈率:-10.53
高:26.15
開:25.58
低:25.02
收:25.43
52周最高:40.65
52周最低:12.10
股本:5,948.52萬
流通股本:4,061.85萬
量比:0.32
換手率:1.17%
股息:- -
股息率:- -
每股收益(TTM):-2.4031
每股收益(LYR):-2.0125
淨資產收益率:-45.31%
總資產收益率:-28.46%
市淨率:4.26
市盈率(LYR):-12.58

資料載入中...

2024/12/06

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/19

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/10/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/28

重要事件披露

Form 8-K - Current report
2024/10/25

重要事件披露

Form 8-K - Current report
2024/10/22

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/22

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/18

重要事件披露

Form 8-K - Current report
2024/10/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities